All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties

Haematologica

Volumn 88, Issue 8, 2003, Pages 895-905

  Marchetti, Marina ^a   Vignoli, Alfonso ^a   Bani, Maria Rosa ^b   Balducci, Donatella ^a   Barbui, Tiziano ^a   Falanga, Anna ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Endothelium; Fibrinolysis; Retinoids; Thrombomodulin; Tissue factor

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; RETINOIC ACID; RETINOIC ACID ALPHA; RETINOIC ACID BETA; RETINOIC ACID DERIVATIVE; RETINOIC ACID GAMMA; RETINOIC ACID RECEPTOR; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; HUMAN CELL; MICROVASCULATURE; PROTEIN EXPRESSION; RECEPTOR SENSITIVITY; UPREGULATION;

BENZOATES; CAPILLARIES; CELL LINE; CELL LINE, TRANSFORMED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HEMOSTASIS; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, RETINOIC ACID; SIMIAN VIRUS 40; SKIN; TETRAHYDRONAPHTHALENES; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; UP-REGULATION;

EID: 0141761416     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Warrell RP, de The H, Wan Z-Y, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993;329:177-89.
2. Toma S, Raffo P, Nicol G, Canavese G, Bernardo G, Margallo E, et al. Biological activity of all-trans-retinoic acid with and without tamoxifen and α2a interferon in breast cancer patients. Int J Oncol 2000; 17:991-1000.
3. Barbui T, Finazzi G, Falanga A. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 1998;91:3093-102.
4. Gouin-Thibault I, Achkar A, Samama MM. The thrombophilic state in cancer patients. Acta Haematol 2001;106:33-42.
5. Hoffman R, Haim N, Brenner B. Cancer and thrombosis revisited. Blood Rev 2001;15:61-7.
6. Rickles FR, Levine M, Edwards RL Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992;11:237-48.
7. Donati MB, Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 2001;106:18-24.
8. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in cancer patients. Semin Thromb Hemost 1999;25:173-82.
9. Falanga A, Iacoviello, L, Evangelista V, Consonni R, Belotti D, D'Orazio A, et al. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia given all-trans-retinoic acid. Blood 1995;86:1072-81.
10. Balducci D, Marchetti M, Suardi S, Barbui T, Falanga A. All-trans-retinoic acid (ATRA) reduces procoagulant activity (PCA) and induces apoptosis in human breast cancer cells Thromb Haemost 2001; Suppl:OC904[Abstract].
11. Falanga A, Toma S, Marchetti M, Palumbo R, Raffo P, Marziali S, et al. Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer. Am J Hematol 2002;70:9-15.
12. Ishii H, Horie S, Kizaki K, Kazama M. Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumour necrosis factor. Blood 1992;80:2556-62.
13. Falanga A, Marchetti M, Giovanelli S, Barbui T. All-trans retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4). Blood 1996;87:613-7.
14. Horie S, Kizaki K, Ishii H, Kazama M. Retinoic acid stimulates expression of thrombomodulin, a cell surface anticoagulant glycoprotein, on human endothelial cells: differences between up-regulation of thrombomodulin by retinoic acid and cyclic AMP. Biochemistry 1992;281:149-54.
15. Kooistra T, Opdenberg J, Toet K, Hendriks HFJ, Van den Hoogen RM, Emeis JJ. Stimulation of tissue-type plasminogen activator by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb Haemost 1991;65:565-72.
16. Medh RD, Santell L, Levin EG. Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activation. Blood 1992;80:981-7.
17. Garlanda C, Dejana E. Heterogeneity of endothelial cells, specific markers. Arterioscler Thromb Vasc Biol 1997; 17:1193-202.
18. Pemrick SM, Lucas DA, Grippo JF. The retinoid receptors. Leukemia 1994;8 Suppl 3:1-10.
19. Bollag W, Isnardi L, Jablonska S, Klaus M, Majewski S, Pirson W, et al. Links between pharmacological properties of retinoids and nuclear retinoid receptors. Int J Cancer 1997;70:470-2.
20. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-90.
21. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical cord veins. Identification of morphology and immunologic criteria. J Clin Invest 1973;52:2745-56.
22. Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini E, Gambacorti Passerini C, et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid (ATRA) in acute promyelocytic leukemia cells. Blood 1998;92:143-51.
23. Vikhanskaya F, Bani, MR, Borsotti P, Ghilardi C, Ceruti R, Ghisleni G, et al. p73 overexpression increases VEGF and reduces thrombospondin-1 production: implication for tumour angiogenesis. Oncogene 2001;20:7293-300.
24. Napoleone E, Di Santo A, Camera M, Tremoli E, Lorenzet R. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 2000;86:139-43.
25. Oeth P, Yao J, Fan ST, Mackman N. Retinoic acid selectively inhibits lipopolysaccharide induction of tissue factor gene expression in human monocytes. Blood 1998;91:2857-65.
26. Falanga A, Vignoli A, Marchetti M, Barbui T. Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells. Leukaemia 2003; in press.
27. Ribeiro MJ, Phillips DJ, Benson JM, Evatt BL, Ades EW, Hooper WC. Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). A representative in vitro model for microvascular endothelium. Thromb Res 1995;79:153-61.
28. Xu Y, Swerlick,RA, Sepp N, Bosse D, Ades EW, Lawley TJ. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol 1994;102:833-7.
29. Saito T, Koyama T, Nagata K, Kamiyama R, Hirosawa S. Anti-coagulant effects of retinoic acids on leukemia cells. Blood 1996;87:657-65.
30. Zhu J, Guo WM, Yao YY, Zhao WL, Pan L, Cai X, et al. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia 1999;13:1062-70.
31. Koyama T, Hirosawa S. Anticoagulant effects of synthetic retinoids and activated vitamin D3. Semin Thromb Hemost 1998;24:217-26.
32. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78:747-54.
33. Schule R, Rangarajan P, Yang N, Kliewer S, Ransone U, Bolado J, et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 1991;88:6092-6.
34. Kooistra T, Lansink M, Arts J, Sitter T, Toet K. Involvement of retinoic acid receptor α in the stimulation of tissue-type plasminogen activator gene expression in human endothelial cells. Eur J Biochem 1995;232:425-32.
35. Thompson EA, Nelles L, Collen D. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells. Eur J Biochem 1991;201:627-32.
36. Lansink M, Kooistra T. Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor beta 2 induction. Blood 1996;88:531-41.
37. Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990;75:329-36.
38. Dittman WA, Nelson SC, Greer PK, Horton ET, Palomba ML, McCachren SS. Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in human thrombomodulin gene. J Biol Chem 1994;269:16925-32.
39. Horie S, Ishii H, Matsumoto F, Kusano M, Kizaki K, Matsuda J, Kazama M. Acceleration of thrombomodulin gene transcription by retinoic acid. Retinoic acid receptors and Sp1 regulate the promoter activity through interactions with two different sequences in the 5′-flanking region of human gen. J Biol Chem 2001;276:2440-50.